Connect with us

Hi, what are you looking for?


US Senators Press Federal Officials to Expand Medical Pot Research

U.S. Senators Cory Booker (D-NJ) and Kirsten Gillibrand (D-NY) urged the federal government to allow increased research on medicinal cannabis during a hearing held by the Senate Caucus on International Narcotics Control last week.

Speaking before officials from the National Institute on Drug Abuse and the Food and Drug Administration, Gillibrand did not mince words, openly criticizing an FDA official for not expanding drug trials for children suffering deadly seizures.

“You have thousands of patients in my state alone who need access to this medicine, and they don’t get accepted by the drug trials,” she said to FDA Deputy Director Douglas Throckmorton.

“That’s outrageous,” added Gillibrand, who is backing proposed federal legislation to mandate increased medical marijuana research.

For their part, NIDA and FDA officials agreed with lawmakers that barriers to cannabis research should be removed, and they collectively blamed the DEA.

NIDA may only conduct research on medical marijuana provided by the DEA. Though the DEA has increased the amount of weed for research in recent years, the agency won’t license any other pot cultivator other than the University of Mississippi, which produces sub-standard cannabis flowers compared to high-potency, medicinally effective strains available from cultivation experts in states like Colorado and California.

It could be argued that by only providing lower-grade cannabis, marijuana’s efficacy is diminished in the limited research that is conducted, furthering the DEA’s goal of keeping pot Schedule I—classified as having no medical use. Hopefully, the work of legislators like Booker and Gillibrand will lead to improved and expanded medical pot studies.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


HT Newsletter

Subscribe for exclusive access to deals, free giveaways and more!

Thank you for subscribing.

Something went wrong.


You May Also Like


A cannabis lobbying group is asking the DEA to leave cannabis research to health experts.


The move will make it easier for patients and caretakers to access the medication.


The DEA seems to be advancing plans to expand medical marijuana research.


This year, you can dispose of prescription drugs and vaping products.


The Office of the Inspector General called out the DEA for its role in the opioid epidemic.


The DEA needs more growers to assist in cannabis research.


UC Davis is teaming up with Biopharmaceutical Research Company.


Federal agencies are trying to free up space by burning evidence from narcotics busts to ash.

Do NOT follow this link or you will be banned from the site!